Terms: = Pancreatic cancer AND CALCB, Calcitonin AND Diagnosis
30 results:
1. Neuroendocrine tumor with diarrhea: not always the usual suspects - a case report of metastatic calcitoninoma with literature review.
Vlaemynck K; De Man M; De Man K; Hoorens A; Geboes K
Acta Clin Belg; 2021 Jun; 76(3):239-243. PubMed ID: 31900071
[TBL] [Abstract] [Full Text] [Related]
2. calcitonin-Producing Neuroendocrine Neoplasms of the Pancreas: Clinicopathological Study of 25 Cases and Review of the Literature.
Uccella S; Blank A; Maragliano R; Sessa F; Perren A; La Rosa S
Endocr Pathol; 2017 Dec; 28(4):351-361. PubMed ID: 29063495
[TBL] [Abstract] [Full Text] [Related]
3. AACE/ACE disease state clinical review: pancreatic neuroendocrine incidentalomas.
Herrera MF; Åkerström G; Angelos P; Grant CS; Hoff AO; Pantoja JP; Pérez-Johnston R; Sahani DV; Wong RJ; Randolph G
Endocr Pract; 2015 May; 21(5):546-53. PubMed ID: 25962093
[TBL] [Abstract] [Full Text] [Related]
4. Medullary thyroid cancer secreting carbohydrate antigen 19-9 (Ca 19-9): a fatal case report.
Elisei R; Lorusso L; Romei C; Bottici V; Mazzeo S; Giani C; Fiore E; Torregrossa L; Insilla AC; Basolo F; Guerini A; Menghi A; Poletti A; Cugudda L; Vitti P
J Clin Endocrinol Metab; 2013 Sep; 98(9):3550-4. PubMed ID: 23861463
[TBL] [Abstract] [Full Text] [Related]
5. Metastatic medullary thyroid cancer presenting with elevated levels of CA 19-9 and CA 125.
Milman S; Whitney KD; Fleischer N
Thyroid; 2011 Aug; 21(8):913-6. PubMed ID: 21751886
[TBL] [Abstract] [Full Text] [Related]
6. [Diagnostics and treatment in functional pancreatic neuroendocrine tumours].
Müssig K; Dudziak K; Horger M; Anlauf M; Goretzki PE
Dtsch Med Wochenschr; 2011 Jun; 136(24):1319-30. PubMed ID: 21656454
[TBL] [Abstract] [Full Text] [Related]
7. calcitonin-secreting pancreatic endocrine tumors: systematic analysis of a rare tumor entity.
Schneider R; Waldmann J; Swaid Z; Ramaswamy A; Fendrich V; Bartsch DK; Schlosser K
Pancreas; 2011 Mar; 40(2):213-21. PubMed ID: 21178652
[TBL] [Abstract] [Full Text] [Related]
8. Hypercalcitonemia revealing a somatostatinoma.
Do Cao C; Mekinian A; Ladsous M; Aubert S; D'Herbomez M; Pattou F; Bourdelle-Hego MF; Wémeau JL
Ann Endocrinol (Paris); 2010 Dec; 71(6):553-7. PubMed ID: 20817146
[TBL] [Abstract] [Full Text] [Related]
9. Duodeno-pancreatic neuroendocrine tumours.
Peros G; Sakorafas GH; Konstantoudakis G; Giannopoulos GA; Petropoulou K; Parasi A
Eur J Cancer Care (Engl); 2010 May; 19(3):393-402. PubMed ID: 19708940
[TBL] [Abstract] [Full Text] [Related]
10. Uncommon association of germline mutations of RET proto-oncogene and CDKN2A gene.
Foppiani L; Forzano F; Ceccherini I; Bruno W; Ghiorzo P; Caroli F; Quilici P; Bandelloni R; Arlandini A; Sartini G; Cabria M; Del Monte P
Eur J Endocrinol; 2008 Mar; 158(3):417-22. PubMed ID: 18299477
[TBL] [Abstract] [Full Text] [Related]
11. Incidental small ampullary somatostatinoma treated with ampullectomy 2 years after diagnosis.
Guercioni G; Marmorale C; Siquini W; Fianchini M; Fianchini A; Landi E
Dig Dis Sci; 2006 Oct; 51(10):1767-72. PubMed ID: 16967313
[TBL] [Abstract] [Full Text] [Related]
12. pancreatic neuroendocrine neoplasms: a current summary of diagnostic, prognostic, and differential diagnostic information.
Wick MR; Graeme-Cook FM
Am J Clin Pathol; 2001 Jun; 115 Suppl():S28-45. PubMed ID: 11993688
[TBL] [Abstract] [Full Text] [Related]
13. Guidelines for diagnosis and therapy of MEN type 1 and type 2.
Brandi ML; Gagel RF; Angeli A; Bilezikian JP; Beck-Peccoz P; Bordi C; Conte-Devolx B; Falchetti A; Gheri RG; Libroia A; Lips CJ; Lombardi G; Mannelli M; Pacini F; Ponder BA; Raue F; Skogseid B; Tamburrano G; Thakker RV; Thompson NW; Tomassetti P; Tonelli F; Wells SA; Marx SJ
J Clin Endocrinol Metab; 2001 Dec; 86(12):5658-71. PubMed ID: 11739416
[TBL] [Abstract] [Full Text] [Related]
14. Malignant carcinoid in two brothers.
Kinova S; Duris I; Kovacova E; Stvrtina S; Galbavy S; Makaiova I
Bratisl Lek Listy; 2001; 102(5):231-4. PubMed ID: 11725374
[TBL] [Abstract] [Full Text] [Related]
15. Overview of chronic diarrhea caused by functional neuroendocrine neoplasms.
Jensen RT
Semin Gastrointest Dis; 1999 Oct; 10(4):156-72. PubMed ID: 10548409
[TBL] [Abstract] [Full Text] [Related]
16. pancreatic endocrine tumors: recent advances.
Jensen RT
Ann Oncol; 1999; 10 Suppl 4():170-6. PubMed ID: 10436815
[TBL] [Abstract] [Full Text] [Related]
17. Gastroenteropancreatic neuroendocrine tumor metastases to the thyroid gland: differential diagnosis with medullary thyroid carcinoma.
Leboulleux S; Baudin E; Young J; Caillou B; Lazar V; Pellegriti G; Ducreux M; Schaison G; Schlumberger M
Eur J Endocrinol; 1999 Mar; 140(3):187-91. PubMed ID: 10216512
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic factors in patients with endocrine tumours of the duodenopancreatic area.
Madeira I; Terris B; Voss M; Denys A; Sauvanet A; Flejou JF; Vilgrain V; Belghiti J; Bernades P; Ruszniewski P
Gut; 1998 Sep; 43(3):422-7. PubMed ID: 9863490
[TBL] [Abstract] [Full Text] [Related]
19. The glucagonoma syndrome. Clinical and pathologic features in 21 patients.
Wermers RA; Fatourechi V; Wynne AG; Kvols LK; Lloyd RV
Medicine (Baltimore); 1996 Mar; 75(2):53-63. PubMed ID: 8606627
[TBL] [Abstract] [Full Text] [Related]
20. Ectopic ACTH syndrome.
Wajchenberg BL; Mendonça B; Liberman B; Adelaide M; Pereira A; Kirschner MA
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):139-51. PubMed ID: 7626446
[TBL] [Abstract] [Full Text] [Related]
[Next]
